IRB Services

Salus IRB provides review for the following:

All phases of research in a variety of therapeutic areas and study designs in the pharmaceutical, biotech, and medical device industries; for single site, multi-site, and large-scale trials.
Behavioral and social sciences research, data collection, repository, surveys, outcomes research, and registries.
FDA-regulated products research (21 CFR Parts 50 and 56) involving human subjects, including drugs and medical devices for human use, biological products, dietary supplements bearing a nutrient or medical claim, and cosmetics.
Research conducted or supported partially or wholly by the Department of Health and Human Services (45 CFR Part 46), the Department of Education, National Institutes of Health, and National Science Foundation.

Salus IRB does not review emergency use, prisoner, human fetus, or neonate research.